SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 30.25-2.9%2:54 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert S. who wrote (7770)11/19/1998 10:37:00 PM
From: Tharos   of 17367
 
>>Regardless of the "proof of concept" thesis, Wall Street does not get excited about therapeutic treatments that target small markets.<<

Better said, "Regardless of the 'proof of concept' thesis, Wall Street does not get excited about therapeutic treatments that it perceives to target small markets." Viagra would be an excellent example of valuation re perception, but then Pfizer followed up on a secondary indication and built clinical trials targeted specifically at one indication, which is the sign of bad clinical practice according to your previous posts.

>>Comparing the internet stocks with the biotech sector is ludicrous.<<
Why?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext